Shirley V. Wang, PhD, FISPE

Brigham and Women's Hospital, Harvard Medical School
Boston, Massachusetts, United States

Dr. Wang is an Assistant Professor at Brigham and Women’s Hospital, Harvard Medical School. Her research is focused on 1) developing innovative, non-traditional analytic methods to understand the safety and effectiveness of medication use in routine clinical care as well as 2) facilitating appropriate use of complex methods for analyzing large observational healthcare data. She has received awards for her methods work from the Society for Epidemiologic Research and the International Society of Pharmacoepidemiology.
Dr. Wang co-led a joint task force for ISPE and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in 2017 which was focused real-world evidence for healthcare decision-making. She is currently leading a second ISPE/ISPOR joint task force focused on developing a standard protocol template to enhance communication and improve validity assessment for decision making Informed by real-world evidence studies. She is on the Steering Committee for a Transparency Initiative led by ISPOR in partnership with ISPE, Duke Margolis, and the National Pharmaceutical Council. She co-directs the REPEAT Initiative, a non-profit program with projects aimed at improving transparency, reproducibility and robustness of evidence from healthcare databases.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Predicting Treatment Effects of a New Drug in a Target Population Based on Randomized Controlled Trial Results

  Friday, August 26, 2022
  2:30 PM – 2:45 PM CEST

• It Takes a Village: Strategic Global Collaborations to Advance RWE Within ISPE

  Friday, August 26, 2022
  3:30 PM – 5:00 PM CEST

• Emulating Stratified Randomized Trials by Propensity Score Methods

  Saturday, August 27, 2022
  9:15 AM – 9:30 AM CEST

• Comparative Evaluation of Automated Approaches for Confounder Selection in Ultra High-dimensional Data with Rare Outcomes

  Saturday, August 27, 2022
  1:00 PM – 1:15 PM CEST

• HARmonized Protocol to Enhance Reproducibility (HARPER): An ISPE-ISPOR Joint Task Force of the RWE Initiative

  Saturday, August 27, 2022
  4:15 PM – 5:45 PM CEST

• Hierarchical Clustering Analysis to Inform Classification of Congenital Malformations for Surveillance of Medication Safety in Pregnancy

  Sunday, August 28, 2022
  9:15 AM – 9:30 AM CEST

• Emulation Differences versus Bias: Implications of Large-scale Emulation of Randomized Clinical Trials Using Clinical Practice Data (RCT-DUPLICATE)

  Sunday, August 28, 2022
  10:30 AM – 12:00 PM CEST